Home › Funds › Logos Global Management LP › CRSP
Logos Global Management LP position in CRSP
CRISPR THERAPEUTICS AG · Health Care
Logos Global Management LP reported holding 300,000 shares of CRSP (CRISPR THERAPEUTICS AG) in its Q2 2026 13F filing — a position valued at US$16.4M, representing 0.70% of its reported portfolio and ranking #41 among its reported holdings. Logos Global Management LP first reported this position in Q2 2026.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How Logos Global Management LP's CRSP position evolved
Logos Global Management LP first disclosed a stake in CRSP in Q2 2026 at 300,000 shares (US$16.4M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 300.00K | $16.36M | New |
About CRSP and 13F data
CRSP (CRISPR THERAPEUTICS AG) is a Health Care company. 32 other funds we track also report a position in CRSP — the largest reported positions include ARK Invest (US$516.0M), Orbis Allan Gray Ltd (US$297.2M), GSK plc (US$175.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CRSP
- ARK Invest 9.46M sh · $516.00M · Q2 2026
- Orbis Allan Gray Ltd 5.45M sh · $297.20M · Q2 2026
- GSK plc 3.22M sh · $175.65M · Q2 2026
- SR ONE CAPITAL MANAGEMENT, LP 2.04M sh · $111.19M · Q2 2026
- Amova Asset Management Americas, Inc. 1.72M sh · $93.76M · Q2 2026
- EcoR1 Capital, LLC 1.39M sh · $75.77M · Q2 2026
- NEA Management Company, LLC 1.06M sh · $57.73M · Q2 2026
More on Logos Global Management LP
FAQ
How long has Logos Global Management LP held CRSP?
Logos Global Management LP has disclosed CRSP holdings in 1 of the last 1 reported quarters, going back to Q2 2026.
What is Logos Global Management LP's current position in CRSP?
As of Q2 2026, Logos Global Management LP holds 300.00K shares of CRSP (CRISPR THERAPEUTICS AG), valued at $16.36M, representing 0.70% of its reported portfolio and ranking #41.
Has Logos Global Management LP been buying or selling CRSP?
In the latest 13F filing (Q2 2026), Logos Global Management LP newly opened its position in CRSP.
Which other funds hold CRSP?
Other major institutional holders of CRSP include ARK Invest, Orbis Allan Gray Ltd, GSK plc, among 32 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.